Remove how-new-drugs-are-priced
article thumbnail

How New Drugs Are Priced

Electronic Health Reporter

drug store and pharmacy sales totaled nearly 297 billion dollars. While there has been a big focus on pharmaceutical companies and their sky-high prices in the media, including previously […]. The article How New Drugs Are Priced appeared first on electronichealthreporter.com.

172
172
article thumbnail

Ketamine is the New Viagra

Bill of Health

Johnson & Johnson’s ketamine-based formulation generated $183 million in Q3, surpassing Pfizer’s erectile dysfunction (ED) drug, which earned $110 million over the same period. Yet, these two drugs have more in common than meets the eye, and the path Spravato has taken looks strangely similar to that of Viagra.

FDA 260
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Magnolia Regional used price transparency IT to get more CHF patients to fill their prescriptions

Healthcare It News

When medications are too expensive, patients may abandon them, regardless of how important they are to their health. The impact of non-adherence is dire in terms of patient outcomes, with up to 125,000 avoidable deaths attributed to non-adherence every year, according to a New England Journal of Medicine study. THE PROBLEM.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016. Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study. New Federal Incentives for Diversity in Clinical Trials.

FDA 184
article thumbnail

CipherHealth Launches Medication Affordability Program to Improve Patient Adherence with Health Systems

HIT Consultant

What You Should Know: – CipherHealth , a leader in patient engagement technology, announced a new Medication Affordability & Adherence Program that aims to increase access to life-saving medications and improve medication adherence for patients by addressing a major barrier: cost.

article thumbnail

High Drug Costs Threatening Affordability of Employer-Sponsored Healthcare

HIT Consultant

Ninety-one percent of employers cited million-dollar treatments approved by the FDA, and 89% pointed to specialty drug spending as a top threat. The problem is that controlling drug costs is complex, and the primary efforts to lower the costs have centered around unpopular programs like prior authorization and employee-centered apps.

Doctors 118
article thumbnail

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

HIT Consultant

Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. But at what price? When a drug costs some $2.8 And neither can citizens; when the outlay rises, prices for insurance, hospital stays, tests, and even tax rates rise as well.